Yam C, Mittendorf EA, Garber HR, Sun R, et al. A phase II study of neoadjuvant atezolizumab and nab-paclitaxel in patients with anthracycline-resistant early-stage triple-negative breast cancer. Breast Cancer Res Treat 2023 Apr 15. doi: 10.1007/s10549-023-06929.
PMID: 37061619